As of 2025-05-16, the EV/EBITDA ratio of Acacia Pharma Group PLC (ACPH.BR) is -0.92. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ACPH.BR's latest enterprise value is 94.43 mil EUR. ACPH.BR's TTM EBITDA according to its financial statements is -102.90 mil EUR. Dividing these 2 quantities gives us the above ACPH.BR EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 4.3x - 12.8x | 7.4x |
| Forward P/E multiples | 5.2x - 8.3x | 6.8x |
| Fair Price | (4.84) - (7.64) | (6.51) |
| Upside | -644.6% - -960.1% | -833.3% |
| Date | EV/EBITDA |